期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

塞来昔布和谷氨酰胺保护癌性恶病质肠粘膜屏障机制探讨 被引量：2

The protection of cancer cachexia mice from intestinal mucosal injury by Celecoxib
下载PDF
导出
摘要 目的探讨塞来昔布和谷氨酰胺保护癌性恶病质小鼠肠粘膜的机制。方法28只恶病质小鼠模型随机分为四组：荷瘤组、塞来昔布、谷氨酰胺组和塞来昔布联合谷氨酰胺组。评价塞来昔布和谷氨酰胺对恶病质鼠体重变化和小肠粘膜萎缩以及血清和小肠组织炎性细胞因子表达的影响。结果塞来昔布和谷氨酰胺均具有抑制恶病质体重下降，保护小肠绒毛，抑制血清中TNFα和IL-6升高、增加sTNFRⅠ、IL-10分泌的作用。二者联用能够升高小肠组织中INF-γ。结论塞来昔布和谷氨酰胺通过调节血清和小肠组织中的炎性反应因子保护肠粘膜，缓解体重下降。 Objective To discuss the protection mechanism of intestinal mucosal injury by Cdecoxib and glutamine of cancer cachexia mice. Methods 28 mice were divided into four groups randomly. The weight loss, the height and width of intestinal villi as well as the thickness of muscular layer and basal layer were com- pared in these groups. The inflammatory cytokines in the mucous membrane and blood serum were tested. Results The body weight loss and mucous membrane of small intestine atrophy were inhibited by Celecoxib and glutamine. TNF and IL - 6 expressions decreased, and sTNFR I and IL - 10 expressions increased in blood serum. INFγ lerel increased in mucous membrane after treated by the Ccleeoxib and glutamine. Conclusion Celecoxib and glutamine can protect the weight loss by inhibiting the inflammation in cancer cachexia mice.
作者 贾云鹤 李明琦 薛伟男 孙梓程 王轶慧 董巍 王平 朱磊 江志伟
机构地区 哈尔滨医科大学附属肿瘤医院结直肠外科 南京军区南京总医院解放军普通外科研究所
出处 《实用肿瘤学杂志》 CAS 2013年第3期246-250,共5页 Practical Oncology Journal
基金 黑龙江省青年基金资助项目（QC08C92） 哈尔滨市科技创新人才研究专项资金项目（2008RFQXS097）
关键词 癌性恶病质 肠粘膜 细胞因子 塞来昔布 谷氨酰胺 Cancer cachexia Intestinal mucosa Cytokines Celecoxib Glutamine
分类号 R735 [医药卫生—肿瘤]
  • 相关文献

参考文献15

  • 1Lacherade JC, Van Delouw A, Planus E, et al. Evaluation of basement membrane degradation during TNF - et - induced increase in epithelial permeability [ J ]. Am J Physiol Lung Call Mol Physiol,2001,281 (1) :L134 - L143.
  • 2Stokkers PC, Camoglio L, van Deventer S J, et al. Tumor nec- rosis t'actor(TNF) in inflammatory bowel disease : gene poly- morptfisms, animal models, and potential for anti - TNF therapy [ J ]. J Inflamm, 1995,47 ( 1 - 2) :97 - 103.
  • 3Nusrat A, Turner JR, Madara JL, et al. Molecular physiology and pathophysiology of tight junctions IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells[J]. Am J Physiol Gastrointest Liver Physiol, 2000,279(5) :G851 - G857.
  • 4Wollheim FA. New functions for COX -2 in health and dis- ease: Report of "The Third International Workshop on COX -2"[ J]. Arthritis Res, 1999,1 ( 1 ) :45 -49.
  • 5McAdam BF, Mardini IA, Habib A, et al. Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation[J]. J Clin In- vest,2000,105 (10) : 1473 - 1482.
  • 6梁君蓉,王新,吴开春,时永全,韩者艺,兰梅,石德红.COX-2抑制剂对成纤维细胞的增殖和细胞外基质产生的影响[J].第四军医大学学报,2004,25(9):811-814. 被引量：4
  • 7Aeberli D, Oertle S, Mauron H, et al. Inhibition of the TNF pathway :use of iniliximab and etanercept as remission indu- cing agents in cases of therapy -resistant chronic inflamma- tory disorders[J]. Swiss Med Wkly,2002,132(29 -30) : 414 -422.
  • 8Prchn JL, Mehdizadeh S, Landers C J, et al. Potential role for TL1A,the new TNF- family member and potent costimula- tor of IFN - gmnma, in mucosal inflammation [ J]. Clin Im- munol,2004,112 ( 1 ) :66 -77.
  • 9McKay DM, Singh PK. Superantigen activation of immune cells evokes epithelial (T84)transport and barrier abnormal- ities via IFN - gamma and TNF alpha: inhibition of in- creased permeability, but not diminished secretory responses by TGF - beta2 [ J ]. J Immunol, 1997,159 ( 5 ) : 2382 - 2390.
  • 10Bissonnette EY, Chin B, Befus AD. Intefferons differential- ly regulate histamine and TNF - alpha in rat intestinal mu- cosal mast cells [ J ]. Immunology, 1995,86 ( 1 ) : 12 - 17.

二级参考文献14

  • 1马永贤,蒋朱明,白满喜,刘跃武,袁建刚,强伯勤,扬乃发,何桂珍.创伤后肠粘膜屏障改变分子生物学机制的研究[J].中华外科杂志,1995,33(6):371-373. 被引量：17
  • 2白满喜,蒋朱明,马永贤,刘跃武.谷氨酰胺双肽对大鼠肠切除后细菌移位的影响[J].中华医学杂志,1996,76(2):116-119. 被引量：16
  • 3Koga H, Sakisaka S, Ohishi M, et al. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: Relevance to tumor differentiation[J]. Hepatology, 1999;29:688-696.
  • 4Kondo M, Yamamoto H, Agano H, et al. Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease free survival in patients with hepatocellular carcinoma[J]. Clin Cancer Res, 1999;5:4005-4012.
  • 5Rahman MA, Dhar DK, Masunaga R, et al. Sulindac and exisulind exhibit a significant antiproliferative effect and induce apoptosis in human hepatocellular carcinoma cell lines[J]. Cancer Res, 2000;60:2085-2089.
  • 6Cheng J, Imanishi H, Amuro Y, et al. NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines [J]. Int Cancer, 2002;99:755-761.
  • 7Denda A, Kitayama W, Murata A, et al. Increased expression of cyclooxygenase-2 protein during rat hepatocarcinogenesis caused by a choline-decient, L-amino acid-defined diet and chemopreventive ecacy of a special inhibitor, nimesulide[J]. Carcinogenesis, 2002;23: 245-256.
  • 8Cheng J, Imanishi H, Iijima H, et al. Expression of cyclooxygenase-2 and cytosolic phospholipase A2 in the liver tissue of patients with chronic hepatitis and liver cirrhosis[J]. Hepatol Res, 2002;23:185-195.
  • 9Okazaki I, Watanabe T, Hozawa S, et al. Reversibility of hepatic fibrosis: From the first report of collagenase in the liver to the possibility of gene therapy for recovery[J]. Keio J Med, 2001;50:58-65.
  • 10Housset C, Guechot J. Hepatic fibrosis: Physiopathology and biological diagnosis[J]. Pathol Biol, 1999;47:886-894.

共引文献4

同被引文献24

引证文献2

二级引证文献8

实用肿瘤学杂志
2013年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部